Laponis Adam 4
4 · Twist Bioscience Corp · Filed Oct 30, 2025
Insider Transaction Report
Form 4
Laponis Adam
Chief Financial Officer
Transactions
- Award
Common Stock
2025-10-28+25,000→ 116,525 total
Footnotes (1)
- [F1]Represents Performance Stock Units for which target criteria was determined to have been met on October 28, 2025. 60% of the PSUs remain subject to time-based vesting and will vest on October 1, 2026, subject to continued service or acceleration of vesting as provided in the award agreement.